Riskpilot← Back to searchSign inGet full accessProTreatment Svinninge ApS
APSActiveCVR 33506589Hovedgaden 7Physiotherapy activities · NACE 8695Est. 20113 employeeswww.protreatment.dk
Revenue 2024
DKK 1,4M
+40% vs 2023
EBITDA margin
54.6%
+12% vs 2023
Equity ratio
41.9%
Financial strength
Net profit 2024
DKK 460K
+21% vs 2023
| Revenue | DKK 1,4M | +40% |
| EBITDA | DKK 779K | +12% |
| Net profit | DKK 460K | +21% |
| Total assets | DKK 1,4M | -44% |
| Equity | DKK 596K | +23% |
| Employees | 3 | — |
Legal name
ProTreatment Svinninge ApS
CVR number
33506589
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
25. februar 2011
Share capital
DKK 80.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af direktionen i forening.
Company purpose
Selskabets formål er at drive fysioterapeutklinik og hermed ligestillet virksomhed
Address
Hovedgaden 7
Phone
+4531489535
Email
svinninge@protreatment.dk
Website
www.protreatment.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1.021 | 880 | 1.180 | 1.193 | 1.591 | 908 | 883 | 694 | 1.015 | 1.425 |
| Staff expenses | -8 | -124 | -165 | -235 | -231 | -410 | -275 | -286 | -242 | -308 | -175 | -175 | -647 |
| EBITDA | — | 679 | 563 | 786 | 649 | 770 | 918 | 1.305 | 666 | 576 | 343 | 693 | 779 |
| Depreciation & amort. | -165 | -165 | -165 | -165 | -249 | -183 | -212 | -198 | -198 | -198 | -197 | -192 | -190 |
| EBIT | — | 514 | 398 | 621 | 399 | 586 | 705 | 1.106 | 468 | 377 | 147 | 501 | 589 |
| Net financials | 0 | -63 | -33 | -25 | -28 | -23 | -51 | -29 | -35 | -8 | -5 | -16 | 1 |
| Profit before tax | — | 451 | 365 | 596 | 371 | 563 | 654 | 1.077 | 433 | 369 | 142 | 486 | 590 |
| Tax | 31 | 113 | 91 | 142 | 81 | 124 | 148 | 238 | 96 | 82 | 31 | 107 | 130 |
| Net profit | — | 338 | 274 | 455 | 290 | 439 | 506 | 840 | 338 | 287 | 111 | 379 | 460 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | -766 | 1.004 | 1.005 | 879 | 1.098 | 950 | 1.928 | 1.767 | 2.147 | 2.007 | 2.058 | 2.545 | 1.420 |
| Equity | — | 419 | 363 | 536 | 426 | 520 | 587 | 921 | 419 | 376 | 207 | 486 | 596 |
| Long-term debt | -892 | 342 | 342 | 0 | 0 | 0 | 0 | 5 | 13 | 0 | 0 | 0 | 0 |
| Short-term debt | -31 | 236 | 295 | 341 | 668 | 408 | 1.272 | 721 | 1.545 | 1.412 | 1.672 | 1.921 | 728 |
| Total debt | -923 | 578 | 637 | 341 | 668 | 408 | 1.272 | 726 | 1.558 | 1.412 | 1.672 | 1.921 | 728 |
EBITDA margin
54.6%
This company
15.8%
Market median
+246% vs market
20122024
Equity ratio
41.9%
This company
38.2%
Market median
+10% vs market
20122024
Return on equity
77.2%
This company
18.4%
Market median
+320% vs market
20122024
Net profit margin
32.3%
This company
8.1%
Market median
+299% vs market
20122024
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20122024
Debt / equity
1.38×
This company
0.62×
Market median
-123% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 66.7% | 66.7% | 2017 |
TheAnk Holding ApS | Company | 15.0% | 15.0% | 2022 |
| Individual | 15.0% | 15.0% | 2018 | |
KM INVEST 1 ApS | Company | 25.0% | 25.0% | 2013 |
| Individual | 15.0% | 15.0% | 2012 | |
J. Slott Holding ApS | Company | 15.0% | 15.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TheAnk Holding ApS
ProTreatment Svinninge ApS Board members of ProTreatment Svinninge ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |